Complete Filing Data
Intellia Therapeutics, Inc. reported Net Income Loss of -$412.69 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Intellia Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$412.7M | -$519.0M | -$481.2M | -$474.2M | -$267.9M | -$134.2M | -$474.2M | -$85.3M | -$67.5M | -$31.6M | -$12.4M |
| Research And Development Expense | $388.9M | $466.3M | $435.1M | $420.0M | $229.8M | $150.4M | $108.4M | $89.1M | $67.6M | $31.8M | $11.2M |
| Operating Income Loss | -$441.0M | -$534.3M | -$515.3M | -$458.2M | -$267.9M | -$136.6M | -$106.4M | -$90.9M | -$69.6M | -$32.2M | -$13.4M |
| General And Administrative Expense | $119.8M | $125.8M | $116.5M | $90.3M | $71.1M | $44.2M | $41.1M | $32.2M | $28.0M | $16.8M | $8.3M |
| Revenue From Contract With Customer Excluding Assessed Tax | $67.7M | $57.9M | $36.3M | $52.1M | $33.1M | $58.0M | $43.1M | $30.4M | $26.1M | $16.5M | |
| Comprehensive Income Net Of Tax | -$412.3M | -$518.3M | -$476.0M | -$479.0M | -$270.5M | -$134.5M | -$99.2M | -$85.4M | -$67.5M | -$31.6M | |
| Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Investment Transferred From Available For Sale To Equity Method Tax | $2.1M | $1.6M | -$3.2M | -$507.0K | $0.00 | $0.00 | |||||
| Other Nonoperating Income Expense | $28.3M | $15.2M | $34.1M | -$16.0M | -$42.0K | $2.4M | $6.8M | ||||
| Income Loss From Equity Method Investments | $0.00 | $0.00 | -$15.6M | -$11.1M | -$1.3M | $0.00 | $0.00 | ||||
| License And Services Revenue | $26.1M | $16.5M | $6.0M | ||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $427.0K | $731.0K | $3.6M | -$1.6M | -$2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$101.3M | -$101.3M | -$114.3M | -$135.7M | -$147.0M | -$107.4M | -$122.2M | -$123.7M | -$103.1M | -$113.2M | -$100.7M | -$146.9M | -$71.6M | -$68.8M | -$46.2M | -$42.2M | -$27.8M | -$32.4M | -$31.8M | -$28.3M | -$23.6M | -$25.7M | -$21.9M | -$19.1M | -$22.7M | -$22.2M | -$21.4M | -$24.0M | -$15.4M | -$15.6M | -$12.6M | -$10.6M | -$7.5M | -$6.9M | -$6.7M | -$5.2M | -$3.0M | -$3.0M | -$1.1M |
| Research And Development Expense | $94.7M | $97.0M | $108.4M | $123.4M | $114.2M | $111.8M | $113.7M | $115.3M | $97.1M | $96.7M | $90.2M | $133.1M | $60.5M | $58.9M | $39.3M | $38.2M | $39.8M | $37.8M | $34.7M | $31.7M | $27.5M | $25.5M | $23.7M | $19.9M | $23.2M | $23.5M | $22.5M | $21.2M | $17.5M | $15.6M | $13.4M | $11.3M | $7.9M | $7.4M | $5.2M | $4.4M | $3.5M | $2.0M | $1.4M |
| Operating Income Loss | -$111.5M | -$110.0M | -$120.8M | -$144.8M | -$139.0M | -$114.0M | -$131.1M | -$132.3M | -$112.0M | -$105.5M | -$98.3M | -$144.2M | -$72.0M | -$69.0M | -$46.4M | -$42.4M | -$28.1M | -$33.0M | -$33.0M | -$29.8M | -$25.3M | -$27.5M | -$23.8M | -$20.7M | -$24.1M | -$23.6M | -$22.4M | -$24.7M | -$15.9M | -$16.0M | -$12.9M | -$10.8M | -$7.7M | -$6.9M | -$6.7M | -$5.5M | -$3.3M | -$3.4M | -$1.2M |
| General And Administrative Expense | $30.5M | $27.2M | $29.0M | $30.5M | $31.8M | $31.1M | $29.4M | $30.7M | $27.4M | $22.1M | $22.1M | $22.4M | $18.7M | $16.7M | $13.6M | $10.8M | $10.6M | $11.5M | $11.3M | $9.0M | $8.4M | $13.1M | $10.5M | $8.7M | $8.3M | $7.8M | $7.4M | $10.2M | $5.7M | $6.4M | $5.7M | $5.1M | $4.7M | $3.7M | $3.2M | $2.8M | $1.5M | $2.8M | $1.1M |
| Revenue From Contract With Customer Excluding Assessed Tax | $13.8M | $14.2M | $16.6M | $9.1M | $7.0M | $28.9M | $12.0M | $13.6M | $12.6M | $13.3M | $14.0M | $11.3M | $7.2M | $6.6M | $6.4M | $6.6M | $22.2M | $16.3M | $12.9M | $10.9M | $10.6M | $11.1M | $10.4M | $7.9M | $7.4M | $7.7M | $7.5M | $6.7M | $7.3M | $5.9M | $6.2M | ||||||||
| Comprehensive Income Net Of Tax | -$101.0M | -$101.7M | -$113.9M | -$131.3M | -$147.2M | -$108.3M | -$121.9M | -$124.9M | -$98.3M | -$113.0M | -$102.2M | -$152.3M | -$71.8M | -$68.8M | -$46.2M | -$28.0M | -$32.6M | -$31.7M | -$23.6M | -$25.5M | -$21.9M | -$22.7M | -$22.2M | -$21.4M | |||||||||||||||
| Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Investment Transferred From Available For Sale To Equity Method Tax | $0.00 | $0.00 | $2.1M | $154.0K | $292.0K | $1.8M | -$805.0K | -$560.0K | -$302.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Other Nonoperating Income Expense | $10.2M | $8.7M | $6.5M | $9.1M | -$7.9M | $6.6M | $8.9M | $8.7M | $8.8M | -$7.7M | -$2.4M | -$2.6M | $349.0K | $211.0K | $220.0K | ||||||||||||||||||||||||
| Income Loss From Equity Method Investments | $0.00 | $0.00 | $0.00 | -$3.9M | -$4.0M | -$3.0M | -$1.8M | -$3.3M | -$2.7M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| License And Services Revenue | $7.5M | $6.7M | $7.3M | $5.9M | $6.2M | $5.6M | $4.9M | $4.2M | $1.8M | $1.7M | $1.7M | $1.4M | $1.3M | ||||||||||||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $337.0K | -$404.0K | $452.0K | $4.5M | -$208.0K | -$821.0K | $142.0K | -$1.5M | $3.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $671.4M | $872.0M | $1.05B | $1.24B | $1.04B | $527.1M | $269.9M | $277.9M | $300.6M | $209.8M | -$21.2M | $7.6M |
| Cash And Cash Equivalents At Carrying Value | $155.5M | $189.2M | $226.7M | $523.5M | $123.4M | $160.0M | $57.2M | $58.9M | $273.1M | $75.8M | $9.8M | |
| Accounts Receivable Net Current | $9.5M | $8.5M | $36.5M | $3.8M | $2.0M | $2.1M | $4.6M | $7.5M | $10.5M | $6.5M | $1.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $167.6M | $202.8M | $240.4M | $535.5M | $125.5M | $164.6M | $57.2M | $58.9M | $340.7M | $273.1M | ||
| Marketable Securities Unrealized Gain Loss | $427.0K | $731.0K | $3.6M | -$1.6M | -$2.1M | -$260.0K | $289.0K | -$28.0K | ||||
| Retained Earnings Accumulated Deficit | -$2.59B | -$2.18B | -$1.66B | -$1.18B | -$703.0M | -$435.1M | -$300.9M | -$201.0M | -$121.1M | -$53.6M | -$21.9M | |
| Property Plant And Equipment Net | $17.7M | $27.4M | $32.8M | $27.9M | $21.0M | $15.9M | $18.0M | $17.1M | $15.3M | $10.6M | $2.7M | |
| Prepaid Expense And Other Assets Current | $68.4M | $29.8M | $49.7M | $20.4M | $18.6M | $17.0M | $5.1M | $3.4M | $3.7M | $1.8M | $810.0K | |
| Liabilities Current | $103.9M | $110.9M | $115.2M | $126.6M | $125.8M | $64.3M | $35.6M | $40.6M | $31.4M | $30.7M | $10.7M | |
| Liabilities And Stockholders Equity | $842.1M | $1.19B | $1.30B | $1.52B | $1.29B | $676.3M | $334.3M | $347.3M | $376.2M | $299.0M | $82.1M | |
| Assets Current | $527.7M | $639.9M | $998.3M | $1.22B | $769.3M | $616.5M | $289.5M | $325.0M | $354.8M | $281.3M | $77.6M | |
| Assets | $842.1M | $1.19B | $1.30B | $1.52B | $1.29B | $676.3M | $334.3M | $347.3M | $376.2M | $299.0M | $82.1M | |
| Additional Paid In Capital Common Stock | $3.26B | $3.05B | $2.71B | $2.42B | $1.75B | $962.2M | $570.5M | $479.0M | $421.7M | $263.4M | $735.0K | |
| Accrued Liabilities Current | $49.9M | $55.4M | $67.0M | $60.9M | $43.3M | $25.6M | $13.3M | $10.7M | $8.0M | $5.9M | $2.8M | |
| Accounts Payable Current | $20.3M | $14.6M | $7.5M | $5.2M | $9.7M | $10.5M | $3.9M | $2.7M | $2.2M | $4.7M | $1.4M | |
| Common Stock Value | $12.0K | $10.0K | $9.0K | $9.0K | $7.0K | $7.0K | $5.0K | $5.0K | $4.0K | $4.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$35.2M | -$37.6M | -$295.1M | $410.0M | -$39.1M | $107.4M | -$1.6M | -$281.8M | $67.6M | |||
| Contract With Customer Liability Noncurrent | $0.00 | $18.3M | $38.9M | $19.9M | $63.5M | $51.4M | $16.1M | $28.8M | $44.1M | |||
| Contract With Customer Liability Current | $7.3M | $20.7M | $22.1M | $43.8M | $63.8M | $22.5M | $12.7M | $27.1M | $21.2M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $5.9M | $17.8M | $25.9M | -$4.0M | -$7.6M | -$538.0K | -$3.7M | $676.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0M | $605.0K | -$2.3M | -$7.5M | -$2.6M | $1.0K | $261.0K | -$28.0K | ||||
| Gain Loss On Sale Of Property Plant Equipment | -$527.0K | $76.0K | -$72.0K | $162.0K | $0.00 | -$35.0K | -$1.0K | -$75.0K | -$166.0K | -$13.0K | -$9.0K | |
| Marketable Securities Current | $294.4M | $412.3M | $685.5M | $669.1M | $625.3M | $437.4M | $222.5M | $255.2M | ||||
| Operating Lease Right Of Use Asset | $106.0M | $219.3M | $115.4M | $133.1M | $79.1M | $39.1M | $19.1M | |||||
| Operating Lease Liability Noncurrent | $66.8M | $190.0M | $96.7M | $114.0M | $64.9M | $33.6M | $12.6M | |||||
| Operating Lease Liability Current | $26.5M | $20.2M | $18.6M | $16.7M | $9.1M | $5.7M | $5.7M | |||||
| Restricted Cash Equivalents | $12.1M | $13.6M | $13.6M | $12.0M | $2.1M | $4.6M | $0.00 | |||||
| Other Assets Noncurrent | $2.9M | $5.3M | $6.1M | $7.0M | $1.8M | |||||||
| Marketable Securities Noncurrent | $155.3M | $260.2M | $99.9M | $69.3M | $337.4M | $0.00 | $4.7M | |||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $0.00 | $100.0K | $13.5M | $0.00 | $0.00 | ||||||
| Investments And Other Noncurrent Assets | $35.5M | $44.3M | $42.9M | $40.5M | $29.6M | $4.7M | ||||||
| Right Of Use Assets Acquired Under Operating Lease | $1.3M | $67.1M | $49.4M | $26.4M | $2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $748.4M | $715.3M | $779.9M | $962.6M | $971.1M | $1.04B | $1.04B | $1.10B | $1.19B | $825.0M | $880.5M | $953.8M | $1.11B | $494.8M | $545.9M | $329.6M | $351.6M | $247.8M | $275.7M | $276.9M | $264.3M | $263.3M | $279.3M | $295.5M | $175.8M | $187.6M | $199.9M | $218.1M | $223.6M | -$27.1M | ||||||
| Cash And Cash Equivalents At Carrying Value | $193.4M | $156.2M | $126.9M | $120.5M | $130.8M | $172.0M | $168.0M | $171.8M | $294.2M | $141.2M | $147.8M | $133.4M | $334.7M | $129.9M | $141.5M | $179.7M | $361.7M | $81.0M | $38.4M | $49.1M | $47.1M | $293.2M | $305.5M | $327.8M | $340.7M | $222.3M | $241.0M | $257.6M | $290.6M | $300.7M | $64.2M | $82.6M | $19.8M | $18.5M | ||
| Accounts Receivable Net Current | $11.1M | $11.4M | $10.5M | $8.9M | $12.3M | $36.4M | $6.5M | $5.1M | $4.9M | $4.0M | $2.9M | $1.8M | $2.5M | $2.0M | $953.0K | $1.2M | $3.9M | $13.4M | $3.6M | $4.2M | $3.6M | $2.8M | $8.6M | $7.5M | $4.5M | $2.8M | $2.4M | $1.1M | $1.0M | $1.0M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $207.3M | $207.3M | $148.2M | $134.1M | $144.5M | $185.6M | $181.0M | $183.8M | $306.1M | $149.7M | $156.6M | $140.5M | $337.0M | $132.7M | $145.3M | $181.7M | $363.6M | $81.0M | $38.4M | $49.1M | $47.1M | $293.2M | $305.5M | |||||||||||||
| Marketable Securities Unrealized Gain Loss | $337.0K | -$404.0K | $452.0K | $4.5M | -$208.0K | -$821.0K | $142.0K | -$1.5M | $3.0M | $991.0K | -$932.0K | -$5.1M | -$161.0K | -$1.0K | -$13.0K | -$124.0K | -$218.0K | $112.0K | $81.0K | $196.0K | $87.0K | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$2.49B | -$2.39B | -$2.29B | -$2.05B | -$1.91B | -$1.77B | -$1.53B | -$1.40B | -$1.28B | -$1.06B | -$950.6M | -$849.9M | -$621.8M | -$550.1M | -$481.3M | -$392.9M | -$365.1M | -$332.7M | -$272.6M | -$249.0M | -$223.3M | -$182.0M | -$159.3M | -$137.0M | -$97.2M | -$81.8M | -$66.2M | -$43.0M | -$35.5M | -$28.6M | ||||||
| Property Plant And Equipment Net | $20.4M | $22.8M | $25.1M | $28.8M | $30.3M | $32.1M | $33.8M | $33.2M | $31.6M | $26.6M | $25.9M | $23.7M | $19.9M | $18.5M | $16.2M | $15.6M | $16.4M | $17.3M | $17.2M | $16.7M | $16.7M | $16.9M | $16.6M | $16.0M | $13.6M | $12.6M | $11.4M | $5.5M | $4.4M | $4.2M | ||||||
| Prepaid Expense And Other Assets Current | $59.8M | $24.9M | $37.1M | $43.9M | $53.8M | $56.3M | $32.2M | $26.5M | $25.2M | $26.7M | $18.3M | $18.3M | $14.0M | $18.4M | $16.1M | $7.1M | $5.7M | $6.1M | $6.4M | $4.7M | $3.5M | $2.8M | $3.5M | $2.5M | $2.3M | $2.1M | $1.1M | $972.0K | $1.2M | $745.0K | ||||||
| Liabilities Current | $93.7M | $95.5M | $112.6M | $105.7M | $105.1M | $97.9M | $92.0M | $99.9M | $103.4M | $131.1M | $123.8M | $126.1M | $97.6M | $74.0M | $60.7M | $55.9M | $59.1M | $35.3M | $37.5M | $38.5M | $39.2M | $25.9M | $25.2M | $25.6M | $25.8M | $26.4M | $24.9M | $22.6M | $21.6M | $11.0M | ||||||
| Liabilities And Stockholders Equity | $925.3M | $898.9M | $986.2M | $1.17B | $1.19B | $1.26B | $1.24B | $1.32B | $1.42B | $1.08B | $1.11B | $1.20B | $1.33B | $672.2M | $716.9M | $458.6M | $490.8M | $314.8M | $346.6M | $352.4M | $344.4M | $321.2M | $339.8M | $359.5M | $249.2M | $265.0M | $279.3M | $301.5M | $310.6M | $75.5M | ||||||
| Assets Current | $581.9M | $495.9M | $551.4M | $710.9M | $757.2M | $884.0M | $893.5M | $939.6M | $963.7M | $858.9M | $895.4M | $875.4M | $814.8M | $549.4M | $601.1M | $416.3M | $446.4M | $269.8M | $295.9M | $307.1M | $303.7M | $298.8M | $317.6M | $337.7M | $229.1M | $245.9M | $261.1M | $292.7M | $302.9M | $65.9M | ||||||
| Assets | $925.3M | $898.9M | $986.2M | $1.17B | $1.19B | $1.26B | $1.24B | $1.32B | $1.42B | $1.08B | $1.11B | $1.20B | $1.33B | $672.2M | $716.9M | $458.6M | $490.8M | $314.8M | $346.6M | $352.4M | $344.4M | $321.2M | $339.8M | $359.5M | $249.2M | $265.0M | $279.3M | $301.5M | $310.6M | $75.5M | ||||||
| Additional Paid In Capital Common Stock | $3.24B | $3.11B | $3.07B | $3.01B | $2.88B | $2.80B | $2.57B | $2.51B | $2.47B | $1.90B | $1.84B | $1.81B | $1.73B | $1.04B | $1.03B | $722.5M | $716.5M | $580.1M | $547.9M | $525.6M | $487.6M | $445.2M | $438.6M | $432.5M | $273.0M | $269.4M | $266.1M | $261.1M | $259.1M | $1.5M | ||||||
| Accrued Liabilities Current | $40.8M | $41.6M | $40.8M | $51.2M | $45.1M | $43.3M | $58.0M | $49.5M | $44.8M | $58.4M | $44.9M | $42.9M | $24.6M | $37.2M | $21.2M | $19.3M | $15.4M | $13.1M | $11.6M | $11.9M | $7.7M | $9.9M | $9.2M | $6.6M | $5.9M | $5.3M | $3.6M | $4.8M | $4.3M | $3.0M | ||||||
| Accounts Payable Current | $13.3M | $9.8M | $12.4M | $13.1M | $18.8M | $13.7M | $3.6M | $11.6M | $6.9M | $4.4M | $7.5M | $10.1M | $7.5M | $6.9M | $8.7M | $7.8M | $7.0K | $3.9M | $4.5M | $1.8M | $3.7M | $1.8M | $335.0K | $1.9M | $2.2M | $2.3M | $1.4M | $657.0K | $1.0M | $1.2M | ||||||
| Common Stock Value | $12.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $0.00 | $0.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$54.6M | -$54.8M | -$229.4M | $15.0M | -$19.3M | $23.8M | -$11.8M | |||||||||||||||||||||||||||||
| Contract With Customer Liability Noncurrent | $12.5M | $12.5M | $13.2M | $22.6M | $28.1M | $33.4M | $12.7M | $12.9M | $13.9M | $25.7M | $35.3M | $49.5M | $63.0M | $40.2M | $45.8M | $57.1M | $62.8M | $13.0M | $19.3M | $22.5M | $25.7M | $32.0M | ||||||||||||||
| Contract With Customer Liability Current | $12.2M | $17.2M | $20.7M | $22.2M | $22.2M | $22.2M | $13.3M | $21.9M | $35.3M | $54.8M | $61.8M | $63.8M | $56.8M | $22.5M | $22.5M | $22.5M | $37.9M | $12.6M | $15.8M | $19.7M | $23.4M | $14.3M | ||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.3M | $5.3M | $4.6M | -$2.4M | -$1.2M | $200.0K | $1.4M | |||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $990.0K | $653.0K | $1.1M | $3.3M | -$1.2M | -$947.0K | -$3.6M | -$3.9M | -$2.7M | -$9.4M | -$9.6M | -$8.1M | -$174.0K | -$13.0K | -$12.0K | $31.0K | $155.0K | $373.0K | $336.0K | $255.0K | $59.0K | |||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$1.0K | |||||||||||||||||||||||||||||||||||
| Marketable Securities Current | $317.7M | $303.5M | $376.9M | $537.6M | $560.2M | $619.3M | $686.8M | $736.3M | $639.4M | $687.0M | $726.5M | $721.9M | $463.5M | $399.1M | $442.5M | $228.2M | $75.1M | $169.3M | $247.5M | $222.0M | ||||||||||||||||
| Operating Lease Right Of Use Asset | $117.9M | $129.0M | $138.0M | $100.3M | $105.4M | $110.4M | $118.8M | $123.6M | $128.3M | $101.3M | $73.8M | $76.5M | $81.8M | $77.9M | $22.2M | $23.5M | $24.9M | $20.7M | $20.9M | $21.0M | ||||||||||||||||
| Operating Lease Liability Noncurrent | $70.6M | $75.6M | $80.5M | $82.4M | $87.3M | $92.1M | $101.3M | $105.6M | $109.8M | $84.1M | $60.0M | $62.5M | $67.3M | $63.3M | $64.5M | $16.0M | $17.3M | $18.7M | $14.1M | $14.6M | $15.1M | |||||||||||||||
| Operating Lease Liability Current | $27.4M | $27.0M | $38.8M | $19.2M | $19.0M | $18.8M | $17.1M | $16.8M | $16.3M | $13.6M | $9.6M | $9.3M | $8.7M | $7.4M | $8.3M | $6.2M | $5.8M | $5.7M | $5.5M | $5.1M | $4.4M | |||||||||||||||
| Restricted Cash Equivalents | $14.0M | $14.0M | $21.3M | $13.6M | $13.6M | $13.6M | $13.0M | $12.0M | $12.0M | $8.5M | $8.8M | $7.1M | $2.2M | $2.8M | $3.7M | $1.9M | $1.9M | |||||||||||||||||||
| Other Assets Noncurrent | $5.2M | $5.0M | $5.0M | $4.7M | $4.5M | $4.6M | $2.8M | $3.0M | $2.9M | $3.0M | $5.5M | $5.6M | $5.8M | $6.6M | $6.5M | $6.8M | $3.3M | $3.3M | $5.4M | |||||||||||||||||
| Marketable Securities Noncurrent | $158.8M | $170.9M | $203.4M | $286.6M | $248.8M | $162.1M | $137.8M | $164.0M | $225.0M | $20.5M | $32.6M | $139.5M | $350.5M | $22.3M | $16.7M | $9.9M | $4.7M | |||||||||||||||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $7.8M | -$172.0K | $421.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||
| Investments And Other Noncurrent Assets | $46.2M | $80.2M | $68.3M | $46.8M | $49.8M | $71.0M | $42.4M | $41.0M | $40.9M | $37.0M | $37.1M | $35.5M | ||||||||||||||||||||||||
| Right Of Use Assets Acquired Under Operating Lease | $0.00 | $40.4M | $7.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $131.5M | $185.7M | $130.3M | $583.0M | $736.7M | $371.8M | $76.4M | $40.2M | $143.0M | $167.3M | $70.3M |
| Investing Cash Flow * | $228.0M | $125.6M | -$31.3M | $160.3M | -$550.8M | -$214.5M | $25.2M | -$260.8M | -$10.1M | -$6.2M | -$2.6M |
| Operating Cash Flow * | -$394.7M | -$348.9M | -$394.1M | -$333.3M | -$225.0M | -$49.9M | -$103.2M | -$61.3M | -$65.3M | $36.1M | -$1.8M |
| Share Based Compensation | $80.2M | $154.3M | $134.1M | $91.4M | $47.0M | $19.9M | $15.1M | $17.0M | $15.3M | $6.7M | $1.3M |
| Payments To Acquire Property Plant And Equipment | $1.1M | $5.8M | $14.0M | $13.6M | $12.8M | $3.6M | $6.8M | $6.4M | $10.1M | $6.2M | $2.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $26.4M | -$5.2M | $27.2M | $2.2M | $9.8M | $9.2M | $1.8M | -$310.0K | $1.9M | $979.0K | $525.0K |
| Increase Decrease In Accrued Liabilities | -$5.3M | -$10.4M | $6.0M | $15.9M | $17.3M | $13.0M | $2.3M | $2.8M | $2.4M | $3.1M | $805.0K |
| Increase Decrease In Accounts Payable | $6.0M | $6.8M | $2.5M | -$4.6M | $529.0K | $5.1M | $1.9M | $232.0K | -$488.0K | $1.8M | $335.0K |
| Increase Decrease In Other Operating Assets | -$2.8M | -$917.0K | $707.0K | $1.1M | -$117.0K | -$83.0K | -$153.0K | -$1.0M | -$902.0K | $6.4M | $76.0K |
| Depreciation Depletion And Amortization | $9.8M | $10.3M | $9.0M | $7.6M | $6.9M | $6.3M | $5.6M | $4.5M | $3.0M | $1.1M | $328.0K |
| Increase Decrease In Accounts Receivable | $951.0K | -$27.9M | $32.7M | $1.7M | -$99.0K | -$2.5M | -$2.9M | -$2.9M | $4.0M | $5.5M | $1.0M |
| Proceeds From Stock Options Exercised | $722.0K | $5.9M | $6.6M | $14.5M | $41.1M | $11.6M | $3.1M | $10.7M | $1.2M | $2.0K | |
| Increase Decrease In Contract With Customer Liability | -$28.1M | -$22.1M | -$2.8M | -$63.5M | -$31.4M | $45.1M | -$27.1M | -$3.9M | -$13.0M | $68.0M | |
| Proceeds From Stock Plans | $2.6M | $3.0M | $3.9M | $2.6M | $2.0M | $1.6M | $1.1M | $1.0M | $825.0K | $259.0K | |
| Payments To Acquire Marketable Securities | $322.5M | $935.6M | $904.5M | $429.0M | $1.02B | $473.7M | $297.0M | $254.6M | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $551.7M | $1.07B | $887.1M | $647.6M | $485.6M | $262.8M | $329.0M | ||||
| Increase Decrease In Operating Right Of Use Assets | -$33.1M | -$21.5M | -$19.0M | -$13.1M | -$9.3M | -$6.5M | -$5.7M | ||||
| Increase Decrease In Operating Lease Liabilities | -$55.0M | -$18.0M | -$16.7M | -$9.9M | -$9.1M | -$5.5M | -$4.8M | ||||
| Proceeds From Issuance Of Common Stock | $128.2M | $176.9M | $119.8M | $1.82B | $72.3M | $28.5M | $141.0M | $170.5M | |||
| Payments To Acquire In Process Research And Development | $0.00 | $0.00 | $44.8M | $0.00 | $0.00 | $600.0K | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $0.00 | $60.0M | $2.2M | $47.3M | $58.6M | $4.9M | $4.0M | $6.7M | $47.0K | -$1.2M | $4.3M | ||||||||
| Investing Cash Flow * | $94.3M | $5.9M | -$122.2M | $47.5M | -$25.5M | $57.4M | $5.7M | -$1.9M | -$4.2M | -$1.0M | -$516.0K | ||||||||
| Operating Cash Flow * | -$148.9M | -$120.7M | -$109.3M | -$79.8M | -$52.4M | -$38.5M | -$21.5M | -$17.8M | -$11.4M | -$9.4M | $4.8M | ||||||||
| Share Based Compensation | $21.8M | $34.2M | $27.3M | $18.5M | $6.4M | $4.2M | $4.6M | $4.1M | $2.6M | $2.1M | $1.8M | $812.0K | $579.0K | $151.0K | $115.0K | ||||
| Payments To Acquire Property Plant And Equipment | $735.0K | $2.5M | $3.8M | $1.4M | $2.4M | $845.0K | $1.5M | $1.9M | $4.2M | $1.0M | $516.0K | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$218.0K | $8.7M | $4.8M | -$422.0K | $5.4M | $448.0K | $150.0K | -$1.2M | -$704.0K | -$65.0K | $68.0K | ||||||||
| Increase Decrease In Accrued Liabilities | -$14.4M | -$22.4M | -$17.4M | -$3.7M | -$4.6M | $177.0K | -$2.6M | -$1.6M | -$1.9M | -$134.0K | -$561.0K | ||||||||
| Increase Decrease In Accounts Payable | -$1.9M | $5.6M | $1.2M | -$57.0K | -$917.0K | -$370.0K | $1.4M | $59.0K | -$954.0K | -$87.0K | $360.0K | ||||||||
| Increase Decrease In Other Operating Assets | $13.8M | -$724.0K | $393.0K | $918.0K | $255.0K | -$97.0K | -$84.0K | -$318.0K | -$268.0K | $2.8M | |||||||||
| Depreciation Depletion And Amortization | $2.4M | $2.5M | $2.5M | $2.6M | $2.6M | $2.5M | $2.1M | $1.8M | $1.6M | $1.5M | $1.3M | $1.0M | $660.0K | ||||||
| Increase Decrease In Accounts Receivable | $2.0M | -$29.0K | $1.1M | -$230.0K | -$1.2M | $8.7M | -$4.0M | -$3.0M | -$4.0M | ||||||||||
| Proceeds From Stock Options Exercised | $0.00 | $2.0M | $755.0K | $8.4M | $13.3M | $336.0K | $360.0K | $6.7M | $47.0K | ||||||||||
| Increase Decrease In Contract With Customer Liability | -$5.1M | -$5.4M | -$14.6M | -$14.0M | -$5.6M | -$3.2M | -$6.8M | -$4.5M | |||||||||||
| Proceeds From Stock Plans | |||||||||||||||||||
| Payments To Acquire Marketable Securities | $83.2M | $259.6M | $382.0M | $0.00 | $148.3M | $31.2M | $19.3M | ||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $178.3M | $268.0M | $263.6M | $93.7M | $125.2M | $89.5M | $26.5M | ||||||||||||
| Increase Decrease In Operating Right Of Use Assets | -$7.2M | -$5.0M | -$4.7M | -$2.7M | -$1.6M | -$1.6M | -$1.3M | ||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$29.0M | -$4.5M | -$4.4M | -$2.2M | -$1.4M | -$1.4M | -$1.1M | ||||||||||||
| Proceeds From Issuance Of Common Stock | $38.9M | $45.3M | $4.5M | $3.6M | |||||||||||||||
| Payments To Acquire In Process Research And Development | $0.00 | $44.8M | $0.00 | $200.0K | $300.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.81 | -$5.25 | -$5.42 | -$6.16 | -$3.78 | -$2.40 | -$2.11 | -$1.98 | -$1.88 | -$1.42 | -$51.02 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 70.9K | 56.0K | 47.2K | 43.1M | 36.0M | 22.2M | 243.0K | ||||
| Common Stock Shares Outstanding | 116.3M | 102.0M | 93.0M | 87.1M | 74.5M | 66.2M | 50.2M | 45.2M | 42.4M | 36.0M | 2.6M |
| Common Stock Shares Issued | 116.3M | 102.0M | 93.0M | 87.1M | 74.5M | 66.2M | 66.2M | 45.2M | 42.4M | 36.0M | 2.6M |
| Common Stock Shares Authorized | 240.0M | 240.0M | 240.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 108.4M | 98.8M | 88.8M | 77.0M | 70.9M | 56.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 108.4M | 98.8M | 88.8M | 77.0M | 70.9M | 56.0M | |||||
| Earnings Per Share Basic | $-3.81 | $-5.25 | $-5.42 | $-6.16 | $-3.78 | $-2.40 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.92 | -$0.98 | -$1.10 | -$1.34 | -$1.52 | -$1.12 | -$1.38 | -$1.40 | -$1.17 | -$1.49 | -$1.33 | -$1.96 | -$0.97 | -$1.01 | -$0.69 | -$0.69 | -$0.47 | -$0.61 | -$0.63 | -$0.57 | -$0.49 | -$0.56 | -$0.49 | -$0.43 | -$0.53 | -$0.52 | -$0.51 | -$0.61 | -$0.44 | -$0.45 | -$0.36 | -$0.31 | -$0.22 | -$0.36 | -$9.89 | -$9.57 | -$10.27 | -$2.37 | -$0.85 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 74.8M | 73.7M | 68.2M | 67.2M | 61.3M | 58.8M | 53.4M | 50.5M | 49.4M | 48.6M | 45.8M | 45.2M | 44.2M | 43.2M | 42.8M | 42.0M | 39.2M | 35.2M | 34.9M | 34.7M | 34.5M | 34.3M | 19.1M | 676.0K | 548.0K | 294.0K | 1.3M | 1.3M | |||||||||||
| Common Stock Shares Outstanding | 115.8M | 105.3M | 103.5M | 101.8M | 98.3M | 96.3M | 89.1M | 88.3M | 88.1M | 76.6M | 76.0M | 75.6M | 74.3M | 68.3M | 67.9M | 58.8M | 58.7M | 50.6M | 48.9M | 47.7M | 45.5M | 43.4M | 43.2M | 43.1M | 36.1M | 36.1M | 36.0M | 36.0M | 36.0M | 2.6M | |||||||||
| Common Stock Shares Issued | 115.8M | 105.3M | 103.5M | 101.8M | 98.3M | 96.3M | 89.1M | 88.3M | 88.1M | 76.6M | 76.0M | 75.6M | 74.3M | 68.3M | 67.9M | 58.8M | 58.7M | 50.6M | 48.9M | 47.7M | 45.5M | 43.4M | 43.2M | 43.1M | 36.1M | 36.1M | 36.0M | 36.0M | 36.0M | 2.6M | |||||||||
| Common Stock Shares Authorized | 240.0M | 240.0M | 240.0M | 240.0M | 240.0M | 240.0M | 240.0M | 240.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 50.0M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Weighted Average Number Of Shares Outstanding Basic | 110.2M | 103.7M | 103.5M | 101.0M | 97.0M | 95.5M | 88.6M | 88.2M | 87.8M | 76.0M | 75.8M | 74.8M | 73.7M | 68.2M | |||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 110.2M | 103.7M | 103.5M | 101.0M | 97.0M | 95.5M | 88.6M | 88.2M | 87.8M | 76.0M | 75.8M | 74.8M | 73.7M | 68.2M | |||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.92 | $-0.98 | $-1.10 | $-1.34 | $-1.52 | $-1.12 | $-1.38 | $-1.40 | $-1.17 | $-1.49 | $-1.33 | $-1.96 | $-0.97 | $-1.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $508.7M | $592.1M | $551.6M | $510.3M | $300.9M | $194.6M | $149.5M | $121.3M | $95.7M | $48.6M | $19.5M |
| Investment Income Interest | $29.2M | $47.8M | $49.8M | $8.5M | $1.3M | $2.4M | $6.8M | $5.5M | $2.0M | $525.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $32.0K | $577.0K | $1.5M | $1.6M | $667.0K | $1.5M | $800.0K | $1.1M | $805.0K | $3.1M | $219.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $80.2M | $154.3M | $134.1M | $91.4M | $47.0M | $19.9M | $15.1M | $17.0M | $15.3M | $6.7M | $685.0K |
| Stock Issued During Period Value Stock Options Exercised | $722.0K | $5.9M | $6.6M | $14.5M | $41.1M | $11.6M | $3.1M | $10.7M | $1.2M | $2.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $2.6M | $3.0M | $3.9M | $2.6M | $2.0M | $1.6M | $1.1M | $1.0M | $825.0K | $259.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $125.3M | $124.2M | $137.4M | $153.9M | $146.0M | $142.9M | $143.1M | $145.9M | $124.6M | $118.8M | $112.3M | $155.5M | $79.2M | $75.6M | $52.9M | $49.0M | $50.3M | $49.3M | $46.0M | $40.7M | $35.9M | $38.6M | $34.2M | $28.6M | $31.5M | $31.3M | $29.9M | $31.4M | $23.2M | $21.9M | $19.2M | $16.4M | $12.6M | $11.2M | $8.5M | $7.2M | $5.0M | $4.8M | $2.5M |
| Investment Income Interest | $6.7M | $7.4M | $8.6M | $12.1M | $12.4M | $12.6M | $12.7M | $12.7M | $12.0M | $1.9M | $703.0K | $540.0K | $349.0K | $211.0K | $220.0K | $207.0K | $262.0K | $641.0K | $1.2M | $1.5M | $1.7M | $1.8M | $1.9M | $1.7M | $1.4M | $1.4M | $1.1M | $752.0K | $519.0K | $424.0K | $317.0K | $259.0K | $215.0K | $46.0K | $5.0K | ||||
| Capital Expenditures Incurred But Not Yet Paid | $82.0K | $847.0K | $3.5M | $3.7M | $901.0K | $750.0K | $446.0K | $703.0K | $378.0K | $918.0K | $307.0K | ||||||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $19.6M | $22.0M | $21.8M | $39.6M | $40.9M | $34.2M | $35.4M | $36.4M | $27.3M | ||||||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $97.0K | $2.7M | $1.2M | $2.0M | $4.4M | $465.0K | $755.0K | ||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.2M | $1.7M | $2.1M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.